Cathepsin B may be a potential biomarker in cervical cancer

Histology and Histopathology

Volumn 27, Issue 1, 2012, Pages 79-87

  Wu, Dan ^a   Wang, Huijun ^b   Li, Zhunan ^a   Wang, Lihua ^a   Zheng, Fengyun ^b   Jiang, Juan ^c   Gao, Yongtao ^a   Zhong, Huifang ^a   Huang, Yong ^a   Suo, Zhenhe ^d  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cathepsin B; Cervical cancer; Invasion; Metastasis; RNA interference

Indexed keywords

CATHEPSIN B; CTSB PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CANCER INVASION; CELL MOTION; CELL PROLIFERATION; CHINA; ENZYMOLOGY; FEMALE; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; METASTASIS; MIDDLE AGED; MOUSE; NUDE MOUSE; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; TIME; TUMOR VOLUME; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; WESTERN BLOTTING;

ADULT; ANIMALS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CATHEPSIN B; CELL MOVEMENT; CELL PROLIFERATION; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHINA; FEMALE; HELA CELLS; HUMANS; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 82755189027     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Devetzi M., Scorilas A., Tsiambas E., Sameni M., Fotiou S., Sloane B.F. and Talieri M. (2009). Cathepsin B protein levels in endometrial cancer: Potential value as a tumour biomarker. Gynecol. Oncol. 112, 531-536.
2. Hornebeck W., Emonard H., Monboisse J.C. and Bellon G. (2002). Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin. Cancer Biol. 12, 231-241.
3. Hughes S.J., Glover T.W., Zhu X.X., Kuick R., Thoraval D., Orringer M.B., Beer D.G. and Hanash S. (1998). A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma. Proc. Natl. Acad. Sci. USA 95, 12410-12415.
4. Iacobuzio-Donahue C.A., Shuja S., Cai J., Peng P. and Murnane M.J. (1997). Elevations in cathepsin B protein content and enzyme activity occur independently of glycosylation during colorectal tumor progression. J. Biol. Chem. 272, 29190-29199.
5. Jedinak A. and Maliar T. (2005). Inhibitors of proteases as anticancer drugs. Neoplasma 52, 185-192.
6. Jiao W.J., Xu, J., Pan H., Wang T.Y. and Shen Y. (2007). Effect of endothelin-1 in esophageal squamous cell carcinoma invasion and its correlation with cathepsin B. World J. Gastroenterol. 13, 4002-4005.
7. Joyce J.A., Baruch A., Chehade K., Meyer-Morse N., Giraudo E., Tsai F.Y., Greenbaum D.C., Hager J.H., Bogyo M. and Hanahan D. (2004). Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 5, 443-453.
8. Kolwijck E., Massuger L.F., Thomas C.M., Span P.N., Krasovec M., Kos J. and Sweep F.C. (2010). Cathepsins B, L and cystatin C in cyst fluid of ovarian tumors. J. Cancer Res. Clin. Oncol. 136, 771-778.
9. Long H.J. 3rd (2007). Management of metastatic cervical cancer: review of the literature. J. Clin. Oncol. 25, 2966-2974.
10. Nishikawa H., Ozaki Y., Nakanishi T., Blomgren K., Tada T., Arakawa A. and Suzumori K. (2004). The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer. Gynecol. Oncol. 92, 881-886.
11. Nomura T. and Katunuma N. (2005). Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J. Med. Invest. 52, 1-9.
12. Roshy S., Sloane B.F. and Moin K. (2003). Pericellular cathepsin B and malignant progression. Cancer Metastasis Rev. 22, 271-286.
13. Scorilas A., Fotiou S., Tsiambas E., Yotis J., Kotsiandri F., Sameni M., Sloane B.F. and Talieri M. (2002). Determination of cathepsin B expression may offer additional prognostic information for ovarian cancer patients. Biol Chem. 383, 1297-1303.
14. Shiose Y., Ochi Y., Kuga H., Yamashita F. and Hashida M. (2007). Relationship between drug release of DE-310, macromolecular prodrug of DX-8951f, and cathepsins activity in several tumors. Biol. Pharm. Bull. 30, 2365-2370.
15. Sinha A.A., Jamuar M.P., Wilson M.J., Rozhin J. and Sloane B.F. (2001). Plasma membrane association of cathepsin B in human prostate cancer: biochemical and immunogold electron microscopic analysis. Prostate 49, 172-184.
16. Skrzydlewska E., Sulkowska M., Koda M. and Sulkowski S. (2005a). Proteolytic-antiproteolytic balance and its regulation in carcinogenesis. World J. Gastroenterol. 11, 1251-1266.
17. Skrzydlewska E., Sulkowska M., Wincewicz A., Koda M. and Sulkowski S. (2005b). Evaluation of serum cathepsin B and D in relation to clinicopathological staging of colorectal cancer. World J. Gastroenterol. 11, 4225-4229.
18. Sloane B.F., Yan S., Podgorski I., Linebaugh B.E., Cher M.L., Mai J., Cavallo-Medved D., Sameni M., Dosescu J. and Moin K. (2005). Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment. Semin. Cancer Biol. 15, 149-157.
19. Stetler-Stevenson W.G. (2001). The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis. Surg. Oncol. Clin. N. Am. 10, 383-392.
20. Turk V., Turk B., Guncar G., Turk D. and Kos J. (2002). Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer. Adv, Enzyme Regul. 42, 285-303.
21. Vasiljeva O., Korovin M., Gajda M., Brodoefel H., Bojic L., Kruger A., Schurigt U., Sevenich L., Turk B., Peters C. and Reinheckel T. (2008). Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice. Oncogene 27, 4191-4199.
22. Wagenaar-Miller R.A., Gorden L. and Matrisian L.M. (2004). Matrix metalloproteinases in colorectal cancer: is it worth talking about? Cancer Metastasis Rev. 23, 119-135.
23. Wex T., Levy B., Wex H. and Bromme D. (2000). Human cathepsins W and F form a new subgroup of cathepsins that is evolutionary separated from the cathepsin B-and L-like cysteine proteases. Adv. Exp. Med. Biol. 477, 271-280.
24. Wozniak B., Mila-Kierzenkowska C., Wozniak A., Drewa G., Soponska M., Drewa T., Krzyzynska-Malinowska E., Makarewicz R., Kowalski T. and Szmytkowska K. (2008). The effect of combined therapy on activity of cathepsin D and alpha-1-antitrypsin in the blood serum of women with cervical cancer. Eur. J. Gynaecol. Oncol. 29, 617-619.
25. Yan S. and Sloane B.F. (2003). Molecular regulation of human cathepsin B: implication in pathologies. Biol. Chem. 384, 845-854.